Skip to main content

Leuphasyl vs Thymalin

A detailed comparison to help you understand the differences and choose the right peptide for your research goals.

Leuphasyl

Leuphasyl (Pentapeptide-18) is a cosmetic peptide that reduces muscle tension through a mechanism similar to enkephalins. Often combined with Syn-Ake for enhanced anti-wrinkle effects.

Full details →

Thymalin

Thymalin is a polypeptide preparation derived from calf thymus. Developed in Russia, it has been used for decades to support immune function and has shown potential anti-aging effects in long-term studies.

Full details →

Side-by-Side Comparison

AspectLeuphasylThymalin
MechanismMimics enkephalin and binds to enkephalin receptors on muscle cells, reducing acetylcholine release and thereby decreasing muscle contraction intensity.Regulates the ratio of T-cell subpopulations, stimulates cellular immunity, and enhances phagocytosis. Also affects neuroendocrine regulation and may influence melatonin production.
Typical DosageTopical: 3-8% concentration in serums. Often used in combination products with other muscle-relaxing peptides.Clinical protocols: 5-20mg daily intramuscularly for 3-10 days. Often cycled 1-2 times per year for maintenance.
AdministrationTopical application to expression lines. Best results with consistent twice-daily use over 8+ weeks.Intramuscular injection. Usually administered in short courses rather than continuously. Often combined with Epithalamin for anti-aging protocols.
Side EffectsVery well-tolerated topically. No significant adverse effects reported at cosmetic concentrations.Generally well-tolerated. May cause injection site reactions or temporary flu-like symptoms as immune function is modulated.
Best For

Key Differences

Detailed Analysis

Commonalities

Leuphasyl and Thymalin are used for different purposes and have limited overlap in their applications.

Which Should You Choose?

Choose Leuphasyl for Skin Health & Aesthetics. Choose Thymalin for Immune Support, Anti-Aging & Longevity.

Ready to Learn More?